Why is Genus Prime falling/rising?
As of 10-Oct, Genus Prime Infra Ltd is priced at 23.01, having increased by 2.13% recently, but it has declined 10.05% over the past month and 17.53% year-to-date. Despite recent gains and increased investor interest, the stock faces ongoing challenges compared to the broader market and its longer-term performance.
As of 10-Oct, Genus Prime Infra Ltd is currently priced at 23.01, reflecting an increase of 0.48 or 2.13%. The stock has been gaining for the last two days, with a total return of 6.04% during this period. Additionally, the stock has outperformed its sector by 1.74%. Despite this recent uptick, the stock has shown a decline of 10.05% over the past month and 17.53% year-to-date, indicating a challenging performance relative to the broader market. Notably, there has been a significant increase in investor participation, with delivery volume rising by 234.42% against the five-day average, suggesting growing interest in the stock.In the broader market context, the stock's recent performance contrasts with the Sensex, which has gained 1.59% over the past week. While Genus Prime has struggled in the longer term, it has shown impressive growth over three and five years, outperforming the benchmark significantly during those periods. However, the stock's current moving averages indicate that it is performing better than its five-day average but remains below the longer-term averages, which may reflect ongoing volatility. Overall, while there are signs of a short-term recovery, the longer-term trends and recent performance against the benchmark suggest that the stock is still facing challenges.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
